Association between red blood cell transfusion dependence and burden in patients with myelodysplastic syndromes: A systematic literature review and meta‐analysis-Reference-Cited by-同舟云学术

Association between red blood cell transfusion dependence and burden in patients with myelodysplastic syndromes: A systematic literature review and meta‐analysis

Published:2021-04-14 Issue:1 Volume:107 Page:3-23
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Braga Lemos Mayra¹,Rodrigues Sarah Ramalho¹,Schroeder Thomas²,Kulasekararaj Austin G.³^ORCID,Matos Joana E.⁴^ORCID,Tang Derek⁵

Affiliation:

1. Kantar, Health Division São Paulo Brazil

2. Department of Haematology, Oncology and Clinical Immunology University Hospital Düsseldorf Düsseldorf Germany

3. King's College Hospital NHS Foundation Trust and King's College London London UK

4. Kantar, Health Division New York NY USA

5. Bristol Myers Squibb Princeton NJ USA

Funder

Bristol-Myers Squibb

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13619

Reference62 articles.

1. Myelodysplastic syndromes: diagnosis, prognosis, and treatment;Germing U;Dtsch Arztebl Int,2013

2. Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells

3. Revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes;Vardiman JW;Blood,2008

4. Revised International Prognostic Scoring System for Myelodysplastic Syndromes

5. Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lower-Risk Myelodysplastic Syndromes: Putting Anemia Under the Spotlight;American Medical Journal Oncology;2024-07-16

2. Ivosidenib in Chinese patients with relapsed or refractory isocitrate dehydrogenase 1 mutated acute myeloid leukemia: a registry study;Blood Science;2024-06-20

3. A Systematic Literature Review of Predictors of Erythropoiesis-Stimulating Agent Failure in Lower-Risk Myelodysplastic Syndromes;Journal of Clinical Medicine;2024-05-04

4. Senescent Stem Cell Dysfunction and Age-Related Diseases;Stem Cells and Development;2023-10-01

5. Improved benefit of continuing luspatercept therapy: sub-analysis of patients with lower-risk MDS in the MEDALIST study;Annals of Hematology;2023-01-13